EBA 2019 Helsinki
CUTISS AG is present with a booth at the EBA 2019 in Helsinki. Further information about the congress, also for the upcoming events of the EBA can be found under “Learn more”
News
CSEM article on Innosuisse Grant
Swiss researchers want to develop the first-ever automated machine to bioengineer personalised skin grafts for therapy. The denovoCast project, a collaboration between life science start-up Cutiss AG and CSEM, has been awarded a grant of more than CHF 800’000 by Innosuisse.
CUTISS reaches milestone in Clinical Studies
CUTISS reaches milestone: publication of Phase I of the Clinical Studies of denovoSkin!
denovoFix – transport box for skin biopsy
The denovoFix transport box was developed by Astrid Welti as a Bachelor Thesis in cooperation with the Zürcher Hochschule der Künste (ZHdK).
CUTISS receives SME Instrument Grant
CUTISS AG receives SME Instrument Grant for 2.5 Million Euros to automate.
Read more about this on startupticker.ch –
Cutiss, SamanTree Medical and RqMicro have been selected for the SME Instrument. The startups will be supported in the Phase 2 of the SMI Instrument, with up to €2.5 million in funding.
CUTISS amongst Startup Team to fly to Boston – article on venturelab.ch
CUTISS AG is among the 10 Swiss Venture Leaders that will fly to Boston!
Ten new startups have been selected to become the next Venture Leaders Life Sciences 2018. Chosen from among the most promising Life Sciences startups in Switzerland, the team will embark on a fully packed one-week roadshow in Boston. Meet the team at the Startup Champions Seed Night event on May 2nd.
Following in the footsteps of fellow alumni like Insphero or Covagen, the Venture Leaders Life Sciences 2018 team members will join the 17th edition for a deep dive into Boston’s Life Sciences industry between May 27th and June 3rd. For an intense week, the newly constituted Swiss National Startup Team will have the opportunity to build a solid network through exchanges with local peers, meetings with key Medtech and Biotech industry leaders, and pitches in front of investors, all in order to boost their global expansion ambitions. The Boston region is considered to be one of the major Life Sciences hub worldwide, representing an ideal environment for the Swiss-based startups to get exposure and visibility as well showcasing Switzerland as a breeding ground for innovation in Life Sciences.
University of Zurich receives Swissmedic approval
University of Zurich receives Swissmedic approval to commence phase II denovoSkin™ trial for reconstructive surgery in adults and children.
Article in Magazine NATURE
Article about CUTISS in the International journal of science
“Clinical devices and services: Repair shops
Advances in materials and techniques are restoring damaged body parts to full function.”
